Ketorolac Tromethamine Injection, Solution
Product Images NDC 43066-053

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Ketorolac Tromethamine (NDC 43066-053). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Baxter Healthcare Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image-01-container-label-15mg-ml-sd (Image 01 Container Label 15mg mL Sd)

Label for Ketorolac Tromethamine Injection, USP 15 mg/mL in a 1 mL single dose vial. The label indicates use for intravenous and intramuscular administration. It is manufactured for Baxter Healthcare Corporation, Deerfield, IL, and made in India. The label includes NDC 43066-049-01, barcode, lot number, and expiration date area.*

FDA Label Image

Image-01 (Image 01)

Chemical structure of ketorolac tromethamine, showing the molecular formula C15H13NO3 with the tromethamine component C4H11NO3.*

FDA Label Image

Image-02-outer-carton-label-15mg-ml (Image 02 Outer Carton Label 15mg mL)

Carton label for Ketorolac Tromethamine Injection, USP 15 mg/mL, an injection solution for intravenous and intramuscular use. The label indicates a package containing 10 x 1 mL single dose vials. It is labeled Rx only and manufactured for Baxter Healthcare Corporation, Deerfield, IL, USA, with Alembic Pharmaceuticals Limited, India, as a manufacturer. The label includes QR codes for medication guide access and space for batch details and barcode printing.*

FDA Label Image

Image-03-container-label-30 mg-ml-sd (Image 03 Container Label 30 mg mL Sd)

Label for Ketorolac Tromethamine Injection USP 30 mg/mL in a 1 mL single dose vial. The label states it is for intravenous or intramuscular use and indicates the product is manufactured for Baxter Healthcare Corporation. The label includes the NDC 43066-051-01, barcode, lot and expiration date area, with a note that unused portions should be discarded.*

FDA Label Image

Image-04-outer-carton-label-30mg-ml (Image 04 Outer Carton Label 30mg mL)

Packaging label for Ketorolac Tromethamine Injection, USP 30 mg/mL, a solution for intramuscular and intravenous use. The label includes NDC 43066-051-10 and indicates 10 x 1 mL single dose vials. Manufactured for Baxter Healthcare Corporation and by Alembic Pharmaceuticals Limited. The label features dosage information, usage instructions, a QR code for the medication guide, and storage recommendations.*

FDA Label Image

Image-05-container-label-60mg-ml-sd (Image 05 Container Label 60mg mL Sd)

Label for Ketorolac Tromethamine Injection, USP 60 mg/2 mL (30 mg/mL), single-dose vial for intramuscular use. The label includes the NDC 43066-053-01, manufacturer Baxter Healthcare Corporation, and indicates the product is made in India. Features barcode, lot, and expiration spaces, with an unvarnished area of 17 x 7 mm.*

FDA Label Image

Image-06-outer-carton-label-30mg-ml (Image 06 Outer Carton Label 30mg mL)

Packaging label for Ketorolac Tromethamine Injection, USP, 60 mg/2 mL (30 mg/mL) solution for injection. The label indicates it is for intramuscular use only and includes a 10 dose vial count (10 x 2 mL single dose vials). The labeler is Baxter Healthcare Corporation, with manufacturing by Alembic Pharmaceuticals Limited, India. It also contains dosing, storage, and ingredient information alongside a QR code for the medication guide.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.